Common Contracts
1 similar Sales Agreement contracts
Jasper Therapeutics, Inc.Sales Agreement • December 17th, 2024
We have entered into a Controlled Equity OfferingSM Sales Agreement, dated November 10, 2022 (the “Sales Agreement”), with Cantor Fitzgerald & Co. (“Cantor Fitzgerald”), relating to shares of our voting common stock, par value $0.0001 per share (“Common Stock”), offered by this prospectus. In accordance with the terms of the Sales Agreement, we may offer and sell shares of our Common Stock having an aggregate offering price of up to $75.0 million from time to time through or to Cantor Fitzgerald, acting as sales agent or principal.
